When was Nephronomics founded?

Nephronomics was founded in 2023 and raised its 1st funding round 3 years after it was founded.

Where is Nephronomics located?

Nephronomics is headquartered in Dover, United States.

How many employees does Nephronomics have?

As of Sep 30, 2026, the latest employee count at Nephronomics is 6.

Is Nephronomics a funded company?

Nephronomics is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Apr 21, 2026.

When was the latest funding round of Nephronomics?

Nephronomics' latest funding was a $***** Seed round on Apr 21, 2026, with participation from 1 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $2.59B in funding in 2026 to date.

Where does Nephronomics rank among its competitors?

Nephronomics ranks 107th amongst 575 active competitors, of which 81 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Nephronomics, which secured an undisclosed amount in Apr, 2026.

Who are the top competitors of Nephronomics?

Nephronomics' top competitors include Helix, Latch and Sophia Genetics. Among them, Nephronomics secured the most recent funding round in April, 2026.

Nephronomics - 2026 Company Profile, Funding & Competitors

Company Details

Developer of precision therapies for cardio kidney and metabolic diseases. This entity integrates clinical and genomic data with computational models to identify molecular mechanisms underlying renal conditions. It utilizes large databases of patient records and biological samples to stratify patient populations based on genetic and phenotypic profiles. These insights inform the identification of drug targets and the validation of therapeutic outcomes for complex conditions involving the heart, kidneys, and metabolic systems.

Website: www.nephronomics.com/
Email ID: *****@nephronomics.com

Key Metrics

Founded Year

2023

Location

Dover, United States

Stage

Seed

Latest Funding Round

Seed, Apr 21, 2026, $*****

Investors

CerraCap Ventures

Ranked

107^th among 575 active competitors

Employee Count

6 as on Sep 30, 2026

Similar Companies

Helix & 731 more

View Nephronomics' full profile

Nephronomics has raised funding over 1 round. Its latest funding round was a Seed round on Apr 21, 2026 for $*****. 1 investor participated in its latest round. Nephronomics has 1 institutional investor.

Here is the list of recent funding rounds of Nephronomics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 21, 2026	1047515	Seed	6720966	9550170	9609052	2275940

Access funding benchmarks and valuations. Sign up today!

View details of Nephronomics's funding rounds and investors

Nephronomics' employee count trend

Nephronomics has 6 employees as of Sep 26. Here is Nephronomics's employee count trend over the years:

Uncover Nephronomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nephronomics include Helix, Latch and Sophia Genetics. Here is the list of Top 10 competitors of Nephronomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 13 others	73/100
2nd	Latch 2021, San Francisco (United States), Series A	Provider of a web-based platform for genomic bioinformatics	$33M	Lux Capital, Coatue & 7 others	63/100
3rd	Sophia Genetics 2011, Rolle (Switzerland), Public	Provider of artificial intelligence software for analyzing complex medical data	$249M	Generation Investment Management, Endeavour Vision ... & 25 others	58/100
4th	OutSee United Kingdom, Seed	Developer of an artificial intelligence engine for predictive genomics	$5.79M	Ahren, Panacea Venture & 2 others	54/100
5th	Zetta Genomics 2018, Worcester (United Kingdom), Seed	Provider of genomic data analysis software for clinical labs & research organizations	$10.4M	Nina Capital, APEX Ventures & 12 others	54/100
6th	BostonGene 2015, Waltham (United States), Series B	Developer of cloud-based information and analytics platform to treat cancer	$200M	NEC, Japan Industrial Partners & 1 others	53/100
7th	Congenica 2013, Cambridge (United Kingdom), Acquired	Developer of software for clinical genomic interpretation and variant analysis	$81.9M	IDO Investments, Xeraya Capital & 41 others	52/100
8th	Rancho BioSciences 2012, San Diego (United States), Acquired	Data science services and products for life science innovation	-	-	52/100
9th	Advaita Bioinformatics 2005, Plymouth (United States), Funding Raised	Provider of bioinformatics software tools focused on multi-omics pathway analysis	-	Venture for America, America’s Seed Fund & 4 others	52/100
10th	NeoCura 2017, Changping (China), Series A	Provider of an AI-enabled immunotherapy based tumor diagnostic platform	$38.2M	CDH, PICC Capital Investment Management & 5 others	52/100
107th	Nephronomics 2023, Dover (United States), Seed	Developer of precision therapies for cardio kidney and metabolic diseases	-	CerraCap Ventures	32/100